These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7821752)

  • 21. Molecular modeling of an anti-DNA autoantibody (V-88) and mapping of its V region epitopes recognized by heterologous and autoimmune antibodies.
    Hobby P; Ward FJ; Denbury AN; Williams DG; Staines NA; Sutton BJ
    J Immunol; 1998 Sep; 161(6):2944-52. PubMed ID: 9743357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant anti-polyamine antibodies: identification of a conserved binding site motif.
    Johnston JS; Athwal DS
    Protein Eng; 1999 Jun; 12(6):515-21. PubMed ID: 10388849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural properties and mutation patterns of anti-nucleosome monoclonal antibodies are similar to those of anti-DNA antibodies.
    Brard F; Jovelin F; Petit S; Tron F; Gilbert D
    Eur J Immunol; 1996 Jul; 26(7):1587-94. PubMed ID: 8766565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutational analysis of a sequence-specific ssDNA binding lupus autoantibody.
    Cleary J; Glick GD
    Biochemistry; 2003 Jan; 42(1):30-41. PubMed ID: 12515537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association of heavy and light chain variable domains in antibodies: implications for antigen specificity.
    Chailyan A; Marcatili P; Tramontano A
    FEBS J; 2011 Aug; 278(16):2858-66. PubMed ID: 21651726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variable-region-identical antibodies differing in isotype demonstrate differences in fine specificity and idiotype.
    Torres M; May R; Scharff MD; Casadevall A
    J Immunol; 2005 Feb; 174(4):2132-42. PubMed ID: 15699144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling.
    Eigenbrot C; Randal M; Presta L; Carter P; Kossiakoff AA
    J Mol Biol; 1993 Feb; 229(4):969-95. PubMed ID: 8095303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Critical contribution of VH-VL interaction to reshaping of an antibody: the case of humanization of anti-lysozyme antibody, HyHEL-10.
    Nakanishi T; Tsumoto K; Yokota A; Kondo H; Kumagai I
    Protein Sci; 2008 Feb; 17(2):261-70. PubMed ID: 18227432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting antibody complementarity determining region structures without classification.
    Choi Y; Deane CM
    Mol Biosyst; 2011 Dec; 7(12):3327-34. PubMed ID: 22011953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
    Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
    J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Augmented Binary Substitution: Single-pass CDR germ-lining and stabilization of therapeutic antibodies.
    Townsend S; Fennell BJ; Apgar JR; Lambert M; McDonnell B; Grant J; Wade J; Franklin E; Foy N; Ní Shúilleabháin D; Fields C; Darmanin-Sheehan A; King A; Paulsen JE; Hickling TP; Tchistiakova L; Cunningham O; Finlay WJ
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15354-9. PubMed ID: 26621728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural correlates of an anticarcinoma antibody: identification of specificity-determining residues (SDRs) and development of a minimally immunogenic antibody variant by retention of SDRs only.
    Tamura M; Milenic DE; Iwahashi M; Padlan E; Schlom J; Kashmiri SV
    J Immunol; 2000 Feb; 164(3):1432-41. PubMed ID: 10640759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Affinity maturation increases the stability and plasticity of the Fv domain of anti-protein antibodies.
    Acierno JP; Braden BC; Klinke S; Goldbaum FA; Cauerhff A
    J Mol Biol; 2007 Nov; 374(1):130-46. PubMed ID: 17916365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Critical interactions in binding antibody NC41 to influenza N9 neuraminidase: amino acid contacts on the antibody heavy chain.
    Pruett PS; Air GM
    Biochemistry; 1998 Jul; 37(30):10660-70. PubMed ID: 9692956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific binding of a synthetic peptide derived from an antibody complementarity determining region to phosphatidylserine.
    Igarashi K; Asai K; Kaneda M; Umeda M; Inoue K
    J Biochem; 1995 Feb; 117(2):452-7. PubMed ID: 7608138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the domain pairing in chimeric antibodies.
    Teplyakov A; Obmolova G; Carton JM; Gao W; Zhao Y; Gilliland GL
    Mol Immunol; 2010 Aug; 47(14):2422-6. PubMed ID: 20554002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of antigen binding and idiotypic expression by antibodies with polyglycine-replaced complementarity-determining regions.
    Sompuram SR; Den W; Sharon J
    J Immunol; 1996 Feb; 156(3):1071-81. PubMed ID: 8557981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pillars article: an analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity. J. Exp. Med. 1970. 132: 211-250.
    Wu TT; Kabat EA
    J Immunol; 2008 Jun; 180(11):7057-96. PubMed ID: 18490705
    [No Abstract]   [Full Text] [Related]  

  • 39. The structure of a complex between the NC10 antibody and influenza virus neuraminidase and comparison with the overlapping binding site of the NC41 antibody.
    Malby RL; Tulip WR; Harley VR; McKimm-Breschkin JL; Laver WG; Webster RG; Colman PM
    Structure; 1994 Aug; 2(8):733-46. PubMed ID: 7994573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural effects of framework mutations on a humanized anti-lysozyme antibody.
    Holmes MA; Buss TN; Foote J
    J Immunol; 2001 Jul; 167(1):296-301. PubMed ID: 11418663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.